A Single Dose Study Of Antimineralocorticoid Activity Of PF-03882845 In Healthy Volunteers

NCT01314898 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: 3 mg PF-03882845
DRUG: 10 mg PF-03882845
DRUG: 30 mg PF-03882845
DRUG: 100 mg PF-03882845
DRUG: Spironolactone

Sponsor

Pfizer